In Silico Approach towards Designing Virtual Oligopeptides for HRSV

Figure 10

Interaction of antibody with original and designed oligopeptides; arrow represents binding site of oligopeptide with antibody, as shown in the lower right side of each figure. (a1) represents original PGKYKLAVSEK, (a2) represents designed oligopeptide GEKKLVEAPKS, (b1) represents original SGVQPDAPSNDSKDT, (b2) represents designed oligopeptide PDAPSQNDGKDSSTV, (c1) represents original PSTLSVSSGTVYEKHEGLS, (c2) represents designed oligopeptide YHTGSSVSLTSPSLGEVKE, (d1) represents original KREAKQEE, and (d2) designed oligopeptide AEKREKQE.